Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Phenylketonuria Treatment Market: By Product Type: Dietary Supplement, Drugs; By Route of Administration: Oral, Parenteral; By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Drug Stores, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Phenylketonuria Treatment Market Outlook

The global phenylketonuria treatment market stood at a value of around USD 446.7 million in 2020. The industry is further projected to grow at a CAGR of 10% during the forecast period of 2022-2027.

 

Global Phenylketonuria Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The growing prevalence of phenylketonuria and the rising awareness regarding its treatment is driving the growth of the phenylketonuria treatment market globally. The expected increase in the production and commercialisation of new drugs would further fuel the industry growth in the coming years.

 

Properties and Applications

Phenylketonuria or PKU, is a genetic disorder due to which phenylalanine levels in blood increases. Phenylalanine is an amino acid that is derived from food and diet. The elevated phenylalanine level may cause intellectual disability and other health-related issues. Because of the excess phenylalanine in the body, children with phenylketonuria may have a musty odour. Further, patients appear to have light skin and hair colour, as well as other skin conditions like eczema.

 

Global Phenylketonuria Treatment Market By Distribution CHannel

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The global phenylketonuria treatment market can be broadly categorised based on segments like product types, route of administration, distribution channels, and regions.

  • Product Type:
    • Dietary Supplement
    • Drugs
      • Kuvan
      • Palynziq
      • CNSA-001
      • SYNB1618
  • Route of Administration:
    • Oral
    • Parenteral
  • Distribution Channel:
    • Hospital Pharmacies
    • Online Pharmacies
    • Paediatric Clinics
    • Drug Stores

The EMR report looks into the regional phenylketonuria treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Global Phenylketonuria Treatment Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The global phenylketonuria treatment market is being driven by the growing incidence of PKU, increased R&D activities, rising health concern, enhanced diagnostics facilities, and improved health care infrastructure.

The dietary supplement segment, among other product types, accounts for a significant share in the industry owing to its increased preference among health care professionals to treat patients with phenylketonuria. The oral route remains the more preferred route of administration over parenteral due to its ease of administration and convenience. Region-wise, while North America is expected to account for the largest share in the industry, the Asia Pacific is anticipated to see the highest growth rate over the forecast period owing to the presence of increased population and the growing investment in the R&D of phenylketonuria drugs in the region.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global phenylketonuria treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • BioMarin Pharmaceutical Inc.
  • Synlogic, Inc.
  • Retrophin, Inc.
  • Codexis, Inc.
  • SOM Innovation Biotech, S.A.
  • Homology Medicines, Inc.
  • Others

The EMR report gives an in-depth insight into the phenylketonuria treatment market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Route of Administration, Distribution Channel, Region
Breakup by Product Type Dietary Supplement, Drugs
Breakup by Route of Administration Oral, Parenteral
Breakup by Distribution Channel Hospital Pharmacies, Online Pharmacies, Paediatric Clinics, Drug Stores
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered BioMarin Pharmaceutical Inc., Synlogic, Inc., Retrophin, Inc., Codexis, Inc., SOM Innovation Biotech, S.A., Homology Medicines, Inc., Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Phenylketonuria Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Phenylketonuria Treatment Historical Market (2017-2021) 
    8.3    Global Phenylketonuria Treatment Market Forecast (2022-2027)
    8.4    Global Phenylketonuria Treatment Market by Product Type
        8.4.1    Dietary Supplement
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Drugs
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
            8.4.2.4    Breakup by Type
                8.4.2.4.1    Kuvan
                8.4.2.4.2    Palynziq
                8.4.2.4.3    CNSA-001
                8.4.2.4.4    SYNB1618
    8.5    Global Phenylketonuria Treatment Market by Route of Administration 
        8.5.1    Oral
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Parenteral
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
    8.6    Global Phenylketonuria Treatment Market by Distribution Channel
        8.6.1    Hospital Pharmacies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Online Pharmacies
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Paediatric Clinics
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Drug Stores 
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
    8.7    Global Phenylketonuria Treatment Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    BioMarin Pharmaceutical Inc.
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Synlogic, Inc.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Retrophin, Inc.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Codexis, Inc. 
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    SOM Innovation Biotech, S.A.
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Homology Medicines, Inc.
            11.2.6.1    Company Overview
            11.2.6.2    Product Portfolio
            11.2.6.3    Demographic Reach and Achievements
            11.2.6.4    Certifications
        11.2.7    Others
12    Industry Events and Developments


List of Key Figures and Tables

1.    Global Phenylketonuria Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Phenylketonuria Treatment Historical Market: Breakup by Product Type (USD Million), 2017-2021
3.    Global Phenylketonuria Treatment Market Forecast: Breakup by Product Type (USD Million), 2022-2027
4.    Global Phenylketonuria Treatment Historical Market: Breakup by Route of Administration (USD Million), 2017-2021
5.    Global Phenylketonuria Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2022-2027
6.    Global Phenylketonuria Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2017-2021
7.    Global Phenylketonuria Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2022-2027
8.    Global Phenylketonuria Treatment Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Phenylketonuria Treatment Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Phenylketonuria Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Phenylketonuria Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Phenylketonuria Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Phenylketonuria Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Phenylketonuria Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Phenylketonuria Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Phenylketonuria Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Global Phenylketonuria Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Phenylketonuria Treatment Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Phenylketonuria Treatment Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Phenylketonuria Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global phenylketonuria treatment market attained a value of nearly USD 446.7 million.

The market is projected to grow at a CAGR of 10% between 2022 and 2027.

The major drivers of the market include the increase in the production and commercialisation of new drugs, increased research and development activities, rising health concerns, enhanced diagnostics facilities, improved health care infrastructure, increased population, and the growing investment in the development of drugs.

Growing prevalence of phenylketonuria and the rising awareness regarding its treatment are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America,  Middle East and Africa, Europe, and  Asia Pacific with North America accounting for the largest share in the market.

Dietary supplement and drugs are the product types in the market. Drugs are further bifurcated into kuvan, palynziq, CNSA-001, and SYNB1618.

Based on route of administration, the market is divided into oral and parenteral.

The distribution channels are hospital pharmacies, online pharmacies, paediatric clinics, and drug stores.

The major players in the industry are BioMarin Pharmaceutical Inc., Synlogic, Inc., Retrophin, Inc., Codexis, Inc., SOM Innovation Biotech, S.A., and Homology Medicines, Inc., among others.

Analyst Review

The global phenylketonuria treatment market attained a value of nearly USD 446.7 million in 2020, driven by the growing prevalence of phenylketonuria. Aided increase in the production and commercialisation of new drugs and rising awareness regarding its treatment, the market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 10%.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Dietary supplement and drugs are the product types in the market. Drugs are further bifurcated into kuvan, palynziq, CNSA-001, and SYNB1618. Based on route of administration, the market is divided into oral and parenteral. The distribution channels are hospital pharmacies, online pharmacies, paediatric clinics, and drug stores. The major regional markets for phenylketonuria treatment market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa with North America accounting for the largest share in the market. The major players in the industry are BioMarin Pharmaceutical Inc., Synlogic, Inc., Retrophin, Inc., Codexis, Inc., SOM Innovation Biotech, S.A., and Homology Medicines, Inc., among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER